View in EDS HTML Full Text PDF Full Text

Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.

Saved in:
Bibliographic Details
Title: Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.
Authors: Dou Y; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China., Xu K; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China., Deng YQ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China., Jia Z; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Lan J; Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China., Xu X; Vazyme Biotech Co., Ltd., Nanjing, China., Zhang G; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China., Cao T; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Liu P; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Wang X; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Wang X; Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China., Xu L; Vazyme Biotech Co., Ltd., Nanjing, China., Du P; Vazyme Biotech Co., Ltd., Nanjing, China., Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China., Liu H; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China., Li Y; Shanxi Provincial Key Laboratory of Kidney Disease, The Fifth Hospital of Shanxi Medical University, Taiyuan 030012, China., Wu G; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China., Wang K; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Lu B; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China.
Source: Antibody therapeutics [Antib Ther] 2023 Feb 17; Vol. 6 (2), pp. 76-86. Date of Electronic Publication: 2023 Feb 17 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 101730822 Publication Model: eCollection Cited Medium: Internet ISSN: 2516-4236 (Electronic) Linking ISSN: 25164236 NLM ISO Abbreviation: Antib Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37077472
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dou+Y%22">Dou Y</searchLink>; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China.<br /><searchLink fieldCode="AU" term="%22Xu+K%22">Xu K</searchLink>; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.<br /><searchLink fieldCode="AU" term="%22Deng+YQ%22">Deng YQ</searchLink>; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China.<br /><searchLink fieldCode="AU" term="%22Jia+Z%22">Jia Z</searchLink>; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.<br /><searchLink fieldCode="AU" term="%22Lan+J%22">Lan J</searchLink>; Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.<br /><searchLink fieldCode="AU" term="%22Xu+X%22">Xu X</searchLink>; Vazyme Biotech Co., Ltd., Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+G%22">Zhang G</searchLink>; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.<br /><searchLink fieldCode="AU" term="%22Cao+T%22">Cao T</searchLink>; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.<br /><searchLink fieldCode="AU" term="%22Liu+P%22">Liu P</searchLink>; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Beijing Advanced Innovation Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing 100084, China.<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; Vazyme Biotech Co., Ltd., Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Du+P%22">Du P</searchLink>; Vazyme Biotech Co., Ltd., Nanjing, China.<br /><searchLink fieldCode="AU" term="%22Qin+CF%22">Qin CF</searchLink>; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, China.<br /><searchLink fieldCode="AU" term="%22Liu+H%22">Liu H</searchLink>; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Shanxi Provincial Key Laboratory of Kidney Disease, The Fifth Hospital of Shanxi Medical University, Taiyuan 030012, China.<br /><searchLink fieldCode="AU" term="%22Wu+G%22">Wu G</searchLink>; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.<br /><searchLink fieldCode="AU" term="%22Lu+B%22">Lu B</searchLink>; School of Pharmaceutical Sciences, IDG/McGovern Institute for Brain Research, Tsinghua University, Beijing 100084, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101730822%22">Antibody therapeutics</searchLink> [Antib Ther] 2023 Feb 17; Vol. 6 (2), pp. 76-86. <i>Date of Electronic Publication: </i>2023 Feb 17 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101730822 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2516-4236 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225164236%22">25164236 </searchLink><i>NLM ISO Abbreviation: </i>Antib Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37077472
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/abt/tbad002
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 76
    Titles:
      – TitleFull: Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dou Y
      – PersonEntity:
          Name:
            NameFull: Xu K
      – PersonEntity:
          Name:
            NameFull: Deng YQ
      – PersonEntity:
          Name:
            NameFull: Jia Z
      – PersonEntity:
          Name:
            NameFull: Lan J
      – PersonEntity:
          Name:
            NameFull: Xu X
      – PersonEntity:
          Name:
            NameFull: Zhang G
      – PersonEntity:
          Name:
            NameFull: Cao T
      – PersonEntity:
          Name:
            NameFull: Liu P
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Xu L
      – PersonEntity:
          Name:
            NameFull: Du P
      – PersonEntity:
          Name:
            NameFull: Qin CF
      – PersonEntity:
          Name:
            NameFull: Liu H
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Wu G
      – PersonEntity:
          Name:
            NameFull: Wang K
      – PersonEntity:
          Name:
            NameFull: Lu B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 02
              Text: 2023 Feb 17
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2516-4236
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Antibody therapeutics
              Type: main
ResultId 1